ChemoMetec A/S

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:42 2024-04-26 am EDT			5-day change	1st Jan Change
286.6 ^DKK	+1.49%		+0.49%	-26.13%

Apr. 12	Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024	CI
Apr. 12	ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24	CI

Major shareholder announcement - Invesco Ltd.

March 05, 2024 at 06:01 am EST

ANNOUNCEMENT NO. 251

Major shareholder announcement

Major shareholder announcement – Invesco Ltd.

Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Invesco Ltd. has informed ChemoMetec A/S that on 29 February 2024, Invesco Ltd. decreased its holding of voting rights to below 5% of the total voting rights in ChemoMetec A/S.

Additional information

Niels Høy Nielsen, CFO
Telephone (+45) 2551 8724

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies, such as Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca and Johnson & Johnson.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For more information, go to www.chemometec.com

Latest news about ChemoMetec A/S

Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024	Apr. 12	CI
ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24	Apr. 12	CI
ChemoMetec Appoints COO as New CEO	Mar. 13	MT
ChemoMetec A/S Announces CEO Changes	Mar. 13	CI
Transcript : ChemoMetec A/S, H1 2024 Earnings Call, Feb 06, 2024	Feb. 06
ChemoMetec A/S Maintains Earnings Guidance for the Year 2024	Feb. 05	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 05	CI
ChemoMetec A/S Announces Executive Changes	Dec. 20	CI
Transcript : ChemoMetec A/S, 2023 Earnings Call, Sep 14, 2023	23-09-14
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-13	CI
Chemometec A/S Proposes Dividend for the 2022/23 Financial Year	23-09-13	CI
Chemometec A/S Provides Earnings Guidance for the 2023-2024 Financial Year	23-09-13	CI
ChemoMetec A/S Affirms Earnings Guidance for the Fiscal Year 2022/2023	23-05-08	CI
ChemoMetec A/S Appoints Rasmus Kofoed as CEO, Effective No Later Than 1 August 2023	23-04-17	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-08	CI
ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023	23-02-08	CI
Chemometec A/S Announces Resignation of Steen Søndergaard as CEO	22-12-14	CI
ChemoMetec A/S Provides Earnings Guidance for the Financial Year 2022-23	22-11-08	CI
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-15	CI
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-15	CI
ChemoMetec A/S Provides Revenue Guidance for the Fiscal Year 2023	22-09-15	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-08	CI
Chemometec A/S Reaffirms Earnings Guidance for the Financial Year 2021-2022	21-11-04	CI
ChemoMetec Appoints Bent Faurskov as New CFO from 1 October 2021	21-06-30	CI
Chemometec A/S Announces Unaudited Consolidated Earnings Results for the First Half Ended December 31, 2020	21-02-05	CI

Chart ChemoMetec A/S

Duration

Period

More charts

Company Profile

Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Companyâs activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Companyâs analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for ChemoMetec A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

286.6 DKK

Average target price

462.5 DKK

Spread / Average Target

+61.37%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
CHEMOMETEC A/S	-26.13%	714M
SHOCKWAVE MEDICAL, INC.	+73.17%	12.38B
PENUMBRA, INC.	-18.74%	7.92B
MASIMO CORPORATION	+16.15%	7.2B
GETINGE AB	+4.81%	5.84B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+5.99%	5.07B
APT MEDICAL INC.	+27.07%	4.53B
ASAHI INTECC CO., LTD.	-21.67%	3.88B
INARI MEDICAL, INC.	-40.82%	2.23B
SKAN GROUP AG	+1.49%	2.02B

Medical Equipment